跳至主要内容
临床试验/CTRI/2022/04/041654
CTRI/2022/04/041654尚未招募不适用

Evaluation of macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography

Department of Ophthalmology1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年5月4日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
1-To measure Macular and peripapillary OCTA parameters (VD, PD and FAZ dimensions) in systemic hypertension vs control group.

研究概览

简要总结

This study aims at evaluating changes occurring in the microvasculature of the retina primarily evaluated at the macular and peripapillary region through oct angiography in hypertensive patients in comparison to the normal control group. The study aims at picking up subtle signs of microvascular damage as measured by oct and octa technology well before clinical signs of hypertension manifest in the body.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Hypertensive patients on medication for more than 5 years 2.Age: 30-60 years 3.BCVA ≥ 6/12.

排除标准

  • 1.Significant ocular media opacity (in order to maximize good quality images) 2.Grade 3 hypertensive retinopathy and above (according to Keith Wagener Barker classification).
  • 3.Any other ocular pathology, e.g. macular edema, diabetic retinopathy, optic nerve disorders etc.
  • 4.Any intraocular surgery 5.Any other systemic illness.
  • 6.Refractive errors (> +3 D, axial length (AL) >26.0 mm).

结局指标

主要结局

1-To measure Macular and peripapillary OCTA parameters (VD, PD and FAZ dimensions) in systemic hypertension vs control group.

时间窗: Baseline

次要结局

  • 1) Measurement of structural OCT Parameters (CMT, GC-IPL and RNFL thicknesses)(in systemic hypertension vs normal control group.)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验